Connection
Myron Levin to Recombinant Proteins
This is a "connection" page, showing publications Myron Levin has written about Recombinant Proteins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.187 |
|
|
|
-
Cunningham AL, Levin MJ. Herpes Zoster Vaccines. J Infect Dis. 2018 09 22; 218(suppl_2):S127-S133.
Score: 0.116
-
Lopez Bergami P, Gómez KA, Levy GV, Grippo V, Baldi A, Levin MJ. The beta1 adrenergic effects of antibodies against the C-terminal end of the ribosomal P2beta protein of Trypanosoma cruzi associate with a specific pattern of epitope recognition. Clin Exp Immunol. 2005 Oct; 142(1):140-7.
Score: 0.047
-
Levin MJ, Judson FN, Eron L, Bryson YJ, Corey L, Murray M, Scheer RR. Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences. Antimicrob Agents Chemother. 1989 May; 33(5):649-52.
Score: 0.015
-
Gómez EB, Medina G, Ballesta JP, Levin MJ, Téllez-Iñón MT. Acidic ribosomal P proteins are phosphorylated in Trypanosoma cruzi. Int J Parasitol. 2001 Aug; 31(10):1032-9.
Score: 0.009